Cannabis Freedom Index
← History

Medical 🇩🇰 Denmark

Denmark starts a medical cannabis pilot

A four-year trial let any doctor prescribe cannabis products that were not approved as medicines. It was later extended and then made permanent.[1][2]

Index score

1820

+2 points

The story · written by opus-5.5,

Act No. 1668 was signed on 26 December 2017 and took effect six days later. Its first section is one sentence: from 1 January 2018 to 31 December 2021 a trial scheme with medical cannabis for the treatment of people is established. It created a lawful route to cannabis that does not pass through the ordinary approval of medicines.

Outside the medicines law

The Act does not cover cannabis medicines authorised under the Medicines Act. It deals with a different class of product, which it exempts from the medicines and pharmacy laws: cannabis that has not been approved as a medicine in Denmark or anywhere else. The Danish Medicines Agency says these products have generally not been through clinical trials and come with no package leaflet, so the prescribing doctor carries the full responsibility, including for the dose.

The chain

StageRule in the Act
Starting productimported from an EU or EEA country, grown without pesticides, lawful for medical use where it comes from, with its THC and CBD content measured (section 5)
Companyneeds a permit from the Medicines Agency and a licence under the Euphoriants Act (section 9)
Listeach product must be admitted to a list published by the Agency (section 7)
Prescriptionelectronic, and good for one dispensing only (sections 23 and 27)
Pharmacyhands the product over only against a valid prescription (section 28)

Advertising the products is banned. Breaking the rules brings a fine or up to one year and six months in prison. The Act also lets the minister set rules for growing cannabis in Denmark for the scheme.

Which patients

The Act names no illnesses. The Agency’s guidance does: it considers the treatment relevant for nerve pain, cancer pain, pain and spasticity in multiple sclerosis, pain after spinal cord injury, and nausea from chemotherapy, and only after approved medicines have been tried. Any doctor may prescribe, and none is obliged to. The Agency advises against treating anyone under 18.

After the trial

In May 2021 the parties agreed to let doctors go on prescribing for four more years and to make the production side permanent, according to NJORD. The whole scheme became permanent on 1 January 2026.

Why the index moved

Access rises from 0 to 2: a patient can now obtain cannabis lawfully from a pharmacy, though only with a prescription and only from the Agency’s list. Nothing else changes. The Act gives no one a right to grow cannabis or to hold cannabis that was not dispensed to them, and it says nothing about the possession rules that had applied since 2004. The total moves from 18 to 20.[1][2][3]

Score by segment 0 to 10

  1. Possession · 25%2 2
  2. Personal cultivation · 25%1 1
  3. Punishment & enforcement · 20%4 4
  4. Sharing & gifting · 10%1 1
  5. Consumption · 10%1 1
  6. Legal access · 10%0 2+2

The bar shows the score after the change; the tick marks where it stood before. The scores after the change are Denmark's current scores.

References

  1. Retsinformation — Lov nr. 1668 af 26. december 2017 om forsøgsordning med medicinsk cannabisarchived
  2. Danish Medicines Agency — The medical cannabis schemearchived
  3. NJORD Law Firm — Pilot programme continued (27 May 2021)archived

Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.

    ↑↓ to move, ↵ to open.